# Clinical Study on Savolitinib + Osimertinib in Treatment of EGFRm+/MET+ Locally Advanced or Metastatic NSCLC

> clinical trial · VERIFIED · 2026-06-10

Status: ACTIVE_NOT_RECRUITING · Sponsor: Hutchison Medipharma Limited · Condition: Non-small Cell Lung Cancer

- Company: Hutchison Medipharma Limited
- Sector: oncology
- Primary source: https://clinicaltrials.gov/study/NCT05009836

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED.